NCT02817724

Brief Summary

The purpose of this study is to determine if it is better an integral strategy, with a m-health system, when used in addition to a supervised treatment, versus the use of the m-health system alone, to improve the immediate and long-term Quality of Life of breast cancer survivors.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 29, 2016

Completed
2 days until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

October 25, 2017

Status Verified

October 1, 2017

Enrollment Period

1.4 years

First QC Date

June 22, 2016

Last Update Submit

October 24, 2017

Conditions

Keywords

Breast Neoplasmssurvivoroccupational therapymobile applicationsQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Quality of life (QLQ)

    The primary outcome will be assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORT QLQ-C30) version 3.0., and with the European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Questionnaire (EORT QLQ-BR23). Both are the most widely used instruments to measure Quality of Life in cancer patients.

    Participants will be followed over 8 weeks.

Secondary Outcomes (11)

  • Body mass Index

    Participants will be followed over 8 weeks.

  • Fat mass

    Participants will be followed over 8 weeks.

  • Abdominal adipose tissue

    Participants will be followed over 8 weeks.

  • Bone mineral density

    Participants will be followed over 8 weeks.

  • Shoulder Range of Motion (ROM)

    Participants will be followed over 8 weeks.

  • +6 more secondary outcomes

Study Arms (2)

m-Health group

ACTIVE COMPARATOR

BENECA System: The m-health group will use the BENECA app for 8 weeks.

Device: BENECA System

Integral Group

EXPERIMENTAL

BENECA System and Supervised-occupational therapy program: The integral groups will use the BENECA app and they will receive a face-to-face occupational therapy rehabilitation program for 8 weeks.

Device: BENECA SystemOther: Supervised-occupational therapy program

Interventions

BENECA System is a mobile application whit aims to recover a healthy lifestyle in breast cancer survivors (in terms of energy balance: physical activity and dietary).

Integral Groupm-Health group

It is a comprehensive program that covers most of the physical, cognitive and emotional needs of these patients after oncology treatment from occupational therapy perspective.

Integral Group

Eligibility Criteria

Age25 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of stage I, II or IIIA breast cancer.
  • Overweight or obese, according to the Spanish Society for the Study of Obesity.
  • Basic ability to use mobile apps or living with someone who has this ability.
  • Medical clearance of participants.
  • Completion of adjuvant therapy except for hormone therapy.
  • Some functional or Range of Motion (ROM) limitations measures by goniometry and the DASH Questionnaire.
  • Have signed informed consent.

You may not qualify if:

  • History of cancer recurrence.
  • Chronic disease or orthopedic issues that would interfere with the ability to participate in the rehabilitation program.
  • Uncontrolled hypertension (diastolic pressure \> 95mm Hg).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Health Sciences. University of Granada

Granada, 18071, Spain

Location

Related Publications (2)

  • Lozano-Lozano M, Galiano-Castillo N, Martin-Martin L, Pace-Bedetti N, Fernandez-Lao C, Arroyo-Morales M, Cantarero-Villanueva I. Monitoring Energy Balance in Breast Cancer Survivors Using a Mobile App: Reliability Study. JMIR Mhealth Uhealth. 2018 Mar 27;6(3):e67. doi: 10.2196/mhealth.9669.

  • Lozano-Lozano M, Martin-Martin L, Galiano-Castillo N, Alvarez-Salvago F, Cantarero-Villanueva I, Fernandez-Lao C, Sanchez-Salado C, Arroyo-Morales M. Integral strategy to supportive care in breast cancer survivors through occupational therapy and a m-health system: design of a randomized clinical trial. BMC Med Inform Decis Mak. 2016 Nov 25;16(1):150. doi: 10.1186/s12911-016-0394-0.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Manuel Arroyo-Morales, PhD

    Deparment of physiotherapy, Faculty of Health Sciences, University of Granada

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

June 22, 2016

First Posted

June 29, 2016

Study Start

July 1, 2016

Primary Completion

December 1, 2017

Study Completion

July 1, 2019

Last Updated

October 25, 2017

Record last verified: 2017-10

Locations